FIELD: medicine, gastroenterology.
SUBSTANCE: present invention discloses an agent having antispasmodic, antiulcer and antacid action and containing phenyl salicylate, basic bismuth nitrate and belladonna extract, as well as medicinal additives, wherein the product additionally contains the shells of the seeds of psyllium oval and as an extract of belladonna contains a dry extract of belladonna with a total content of alkaloids in terms of hyoscyamine within 1-5% with the following content of ingredients per 1 tablet: phenyl salicylate 0,245-0,255 g; basic bismuth nitrate 0,245-0,255 g; dry belladonna extract 0,014-0,016 g; the shells of the seeds of psyllium oval 0,045-0,055 g; target supplements 0,097-0,120 g.
EFFECT: increase in the therapeutic effect of the claimed agent which is expressed in a more pronounced and faster normalization of motility and function of the gastrointestinal tract, faster recovery of the morphology of intestinal tissues and a faster removal of inflammation.
3 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
DRUG WITH SPASMOLITHIC, DIURETIC AND LITHIOLIC ACTION | 2017 |
|
RU2635459C1 |
SPRAY FOR EMERGENCY PREVENTION OF ACUTE RESPIRATORY VIRAL INFECTIONS | 2017 |
|
RU2665959C1 |
AGENT FOR TREATING ORAL CANDIDIASIS | 2021 |
|
RU2780094C1 |
DRUG WITH LITHOLITHIC, DIURETIC AND ANTI-INFLAMMATORY ACTION | 2017 |
|
RU2635196C1 |
PHARMACEUTICAL COMPOSITION OF SEDATIVE AND ANXIOLYTIC ACTION | 2020 |
|
RU2737701C1 |
COMPOSITION FOR TOPICAL APPLICATION IN THE TREATMENT OF ONYCHOMYCOSIS (OPTIONS) | 2022 |
|
RU2786851C1 |
PHYTOMIXTURE WITH SEDATIVE EFFECT | 2013 |
|
RU2554796C2 |
PHARMACEUTICAL COMPOSITION POSSESSING SEDATIVE AND SPASMOLYTIC ACTION | 2014 |
|
RU2535020C1 |
ANTI-INFLAMMATORY DIMEXID GEL | 2008 |
|
RU2408366C2 |
SEDATIVE AND SPASMOLYTIC AGENT | 2014 |
|
RU2535019C1 |
Authors
Dates
2022-11-23—Published
2021-12-21—Filed